Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
Progressive cognitive decline in combination with a cerebrospinal fluid biomarker pattern of low levels of amyloid-β1-42 and high levels of total tau and phosphorylated tau is typical of Alzheimer's disease. However, several neurodegenerative disorders may overlap with Alzheimer's disease...
Saved in:
Published in | Brain (London, England : 1878) Vol. 138; no. Pt 9; pp. 2716 - 2731 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.09.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!